News
Before hiring a scientist or applying for a grant, Korean biotech startups often face a more basic challenge: finding a place ...
Konyang University Hospital has partnered with Japan's National Institutes for Quantum Science and Technology (QST) to study ...
Yuhan Corp. is exploring various collaborative strategies to develop new obesity drugs. In addition to securing the ...
Rhythm Pharmaceuticals, a U.S. company that bought a global license from LG Chem for its oral orphan obesity drug Bivamelagon ...
Neurophet, a Korean brain imaging software firm, is making a high-stakes bet on Alzheimer’s, and it’s counting on Eli Lilly ...
Four risk factors increase the risk of developing stomach cancer, one of the most common cancers in Korea. These are ...
Astellas Korea will reapply for health insurance coverage for its new drug Vyloy (zolbetuximab), a targeted treatment for ...
A medical society has recommended expanding national mandatory vaccinations for major infectious diseases that threaten the ...
Citrelin (taltirelin), a treatment for spinocerebellar degeneration (SCD), a neurological disease, has crossed the threshold ...
Korea's Lotte Biologics is stacking up its antibody-drug conjugate (ADC) partnerships, this time tapping AbTis, Dong-A ST’s ...
Huons Group held a ceremony Friday at its headquarters in Pangyo, Seongnam, Gyeonggi Province, to commemorate the company’s ...
GC Genome said it presented clinical research validating the early pancreatic cancer prediction performance of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results